ribavirin has been researched along with Latent Tuberculosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujikawa, H; Hasegawa, H; Matsuoka, S; Moriyama, M; Ochiai, T; Watanabe, Y | 1 |
| Mederacke, I; Meyer-Olson, D; Wedemeyer, H; Witte, T | 1 |
| González, S; Velasco, J | 1 |
3 other study(ies) available for ribavirin and Latent Tuberculosis
| Article | Year |
|---|---|
Onset of Tuberculosis from a Pulmonary Latent Tuberculosis Infection during Antiviral Triple Therapy for Chronic Hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Latent Tuberculosis; Male; Oligopeptides; Polyethylene Glycols; Ribavirin; Treatment Outcome | 2016 |
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis.
Topics: Adult; Antiviral Agents; Arthritis, Psoriatic; Drug Therapy, Combination; Etanercept; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunoglobulin G; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Latent Tuberculosis; Male; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Ribavirin | 2011 |
[Tuberculous lymphadenitis after successful treatment of hepatitis C].
Topics: Adult; Antiviral Agents; Cytokines; Hepatitis C, Chronic; Humans; Immunocompromised Host; Interferon-alpha; Latent Tuberculosis; Male; Mycobacterium tuberculosis; Opportunistic Infections; Pakistan; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tuberculosis, Lymph Node | 2011 |